Cargando…
Subcutaneous sumatriptan: results of a peculiar, unpublished, comparative, double-blind, randomised, and controlled trial
Autor principal: | Tfelt-Hansen, Peer |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072486/ https://www.ncbi.nlm.nih.gov/pubmed/21360159 http://dx.doi.org/10.1007/s10194-011-0312-x |
Ejemplares similares
-
Does sumatriptan cross the blood–brain barrier in animals and man?
por: Tfelt-Hansen, Peer Carsten
Publicado: (2009) -
Suggested randomised, controlled trial with frovatriptan
por: Tfelt-Hansen, Peer, et al.
Publicado: (2011) -
Subcutaneous sumatriptan for the treatment of postcraniotomy pain (SUPS trial): protocol for a randomised double-blinded placebo controlled trial
por: Licina, Ana, et al.
Publicado: (2019) -
Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment
por: Tfelt-Hansen, Peer
Publicado: (2007) -
Treatment with sumatriptan 50 mg in the mild
phase of migraine attacks in patients with
infrequent attacks: a randomised, double-blind,
placebo-controlled study
por: Tfelt-Hansen, P., et al.
Publicado: (2006)